04/07/2015 - 10:58am

Private health insurance exchange enrollment doubled to 6 million covered, accordiing to an Accenture report released Tuesday. 

04/06/2015 - 4:08pm

Public health exchange enrollees fill more prescriptions, but also opt more often for generics or 90-day fills, than their commercial plan counterparts. 

 

04/02/2015 - 10:19am

Alere's i Strep A test received marketing clearance from the Food and Drug Administration on Thursday. 

04/01/2015 - 12:13pm

Teva said it expects the product to be available to patients during second-quarter 2015.

04/01/2015 - 11:47am

Dr. Reddy's Laboratories on Wednesday acquired UCB's portfolio of dermatology, respiratory and pediatric products. 

04/01/2015 - 10:54am

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

03/31/2015 - 12:11pm

The drug is Food and Drug Administration-approved to treat opioid-induced constipation in adults with chronic, non-cancer pain. 

03/31/2015 - 10:39am

Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed. 

03/30/2015 - 10:50am

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.